Transcriptome analysis of Burkitt lymphoma cells treated with anti-convulsant drugs that are inhibitors of Epstein-Barr virus lytic reactivation.
Herpesviruses have two distinct life cycle stages, latency and lytic replication. Epstein-Barr virus (EBV), a gamma-herpesvirus, establishes latency in vivo and in cultured cells. Cell lines harboring latent EBV can be induced into the lytic cycle by treatment with chemical inducing agents. In the B...
Main Authors: | Kelly L Gorres, David M Reineke, George Miller |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Acceso en liña: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299198&type=printable |
Títulos similares
-
Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Kelly L. Gorres, et al.
Publicado: (2016-05-01) -
Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
por: Abbie G. Anderson, et al.
Publicado: (2019-05-01) -
Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus
por: Rebecca L. Hutcheson, et al.
Publicado: (2021-01-01) -
Identification of Epstein-Barr Virus Replication Proteins in Burkitt’s Lymphoma Cells
por: Chris Traylen, et al.
Publicado: (2015-10-01) -
Zebularine reactivates silenced <it>E-cadherin </it>but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells
por: Nadal David, et al.
Publicado: (2007-01-01)